Structure for peptidase T01.015: proteasome subunit beta5i

Summary Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Pharma

TERTIARY STRUCTURE DATA
Comment	Resolution	PDB	PDBe	SCOP	CATH	PDBSum	Proteopedia	Reference
Homo sapiens
yeast 20s proteasome with human beta5i (1-138; r57t)	2.40 Å	5L5A	5L5A	5L5A	5L5A	5L5A	5L5A
yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133)	2.80 Å	5L5B	5L5B	5L5B	5L5B	5L5B	5L5B
yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914	2.80 Å	5L5D	5L5D	5L5D	5L5D	5L5D	5L5D
yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib	2.90 Å	5L5E	5L5E	5L5E	5L5E	5L5E	5L5E
yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib	2.50 Å	5L5F	5L5F	5L5F	5L5F	5L5F	5L5F
yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133); complex with PR-924	2.60 Å	5L5H	5L5H	5L5H	5L5H	5L5H	5L5H
yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 9	2.90 Å	5L5I	5L5I	5L5I	5L5I	5L5I	5L5I
yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14	2.90 Å	5L5J	5L5J	5L5J	5L5J	5L5J	5L5J
yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16	2.60 Å	5L5O	5L5O	5L5O	5L5O	5L5O	5L5O
yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17	2.80 Å	5L5P	5L5P	5L5P	5L5P	5L5P	5L5P
yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone 18	2.80 Å	5L5Q	5L5Q	5L5Q	5L5Q	5L5Q	5L5Q
yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133)	2.90 Å	5L5R	5L5R	5L5R	5L5R	5L5R	5L5R
yeast 20s proteasome with human beta5i (1-138; Val31Met mutant) and human beta6 (97-111; 118-133); complex with PR-924	2.60 Å	5L5S	5L5S	5L5S	5L5S	5L5S	5L5S
yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16	2.90 Å	5L5T	5L5T	5L5T	5L5T	5L5T	5L5T
yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 *caveat 5l5u 04c h 301 has wrong chirality at atom c27 04c k 301 has *caveat 2 5l5u wrong chirality at atom c27 04c v 301 h	2.60 Å	5L5U	5L5U	5L5U	5L5U	5L5U	5L5U
yeast 20s proteasome with human beta5i (1-138; Arg57Thr mutant)in complex with PR-924	2.70 Å	5LTT	5LTT	5LTT	5LTT	5LTT	5LTT
yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with thiazole based inhibitor ro19	2.70 Å	5M2B	5M2B	5M2B	5M2B	5M2B	5M2B
cryo-em structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively inhibits activated lymphocytes	3.80 Å	6AVO	6AVO	6AVO	6AVO	6AVO	6AVO